Furthermore, in addition to the clinical and pathologic characteristics investigated in our study, other factors such as smoking status, EGFR mutation status, KRAS mutation status may also affect the survival of patients with lung adenocarcinoma.25, 26. This evidence concerns the gene KRAS and lung adenocarcinoma.